Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 11, 1998, Pages 754-760

  Trautmann, M ^a   Heinemann, M ^a   Zick, R ^a   Moricke A ^a   Seidelmann, M ^b   Berger, D ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CEFTAZIDIME; ENDOTOXIN; IMIPENEM; MEROPENEM;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; LIMULUS LYSATE TEST; MINIMUM INHIBITORY CONCENTRATION; MORPHOLOGY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; SPHEROPLAST;

ANTI-INFECTIVE AGENTS; CEFTAZIDIME; CEPHALOSPORINS; CIPROFLOXACIN; ENDOTOXINS; HUMANS; IMIPENEM; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; THIENAMYCINS;

EID: 0032407545     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050180     Document Type: Article

References (27)

1. Bodey GP, Bolivar R, Fainstein V, Jedeja L: Infections caused by Pseudomonas aeruginosa. Reviews of Infectious Diseases (1984) 5:279-313
2. Cross AS, Opal SM: Endotoxin's role in gram-negative bacterial infection. Current Opinion in Infectious Diseases (1995) 8:156-163
3. Shenep JL, Barton RP, Morgan KA: Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. Journal of Infectious Diseases (1985) 151:1012-1018
4. Van den Berg C, de Neeling AJ, Schot CS, Hustinx WNM, Wemer J, de Wildt DJ: Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scandinavian Journal of Infectious Diseases (1992) 24:619-627
5. Jackson JJ, Kropp H: β-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. Journal of Infectious Diseases (1992) 165:1033-1041
6. Bucklin SE, Fujihara Y, Leeson MC, Morrison DC: Differential antibiotic-induced release of endotoxin from gram-negative bacteria. European Journal of Clinical Microbiology & Infectious Diseases (1994) 13, Supplement 1:43-51
7. Mock CN, Jurkovich GJ, Dries DJ, Maier RV: Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Archives of Surgery (1995) 130:1234-1241
8. Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelman P: Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. Journal of Infectious Diseases (1995) 172:886-891
9. Catchpole RC, Wise R, Thornber D, Andrews JM: In vitro activity of L-627, a new carbapenem. Antimicrobial Agents and Chemotherapy 1992, 36:1928-1934
10. Hoban DJ, Jones RN, Yamane N, Frei R, Trilla A, Pignatari AC: In vitro activity of three carbapenem antibiotics. Diagnostic Microbiology and Infectious Disease (1993) 17:299-305
11. Sumita Y, Fukasawa M, Okunda T: Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes. Journal of Antibiotics (1990) 43:314-320
12. Pryka RD, Haig GM: Meropenem: a new carbapenem antimicrobial. Annals of Pharmacotherapy (1994) 28:1045-1054
13. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. Approved standard M7-A3. NCCLS Villanova, PA (1993)
14. Trautmann M, Zick R, Rukavina T, Cross AS, Marre R: Antibiotic-induced release of endotoxin: in vitro comparison of meropenem and other antibiotics. Journal of Antimicrobial Chemotherapy (1998) 41:163-169
15. Pitt TL: Epidemiological typing of Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases (1988) 7:238-247
16. Berger D, Marzing E, Marzing M, Beger HG: Quantitative endotoxin determination in blood - chromogenic modification of the Limulus amebocyte lysate test. European Journal of Surgical Research (1988) 20:128-136
17. Livermore DM, Yang Y: Comparative activity of meropenem against Pseudomonas aeruginosa strains with well characterized resistance mechanisms. Journal of Antimicrobial Chemotherapy (1989) 24, Supplement A: 149-159
18. Edwards JR: Laboratory data which differentiate meropenem and imipenem. Scandinavian Journal of Infectious Diseases (1995) Supplement 96:5-10
19. Lang C, Beuth J, Ko HL, Tunggal L, Pulverer G: Antibacterial in-vitro activity of meropenem against 200 clinical isolates in comparison to 11 selected antibiotics. International Journal of Medical Microbiology, Virology, Parasitology and Infectious Diseases (1992) 277:485-492
20. Cometta A, Calandra T, Gaya H, Zinner H, de Bock R, del Favero A, Bucaneve G, Crokaert F, Kern WV, Klastersky J, Langenaeken J, Micozzi A, Padmos A, Paesmans M, Viscoli C, Glauser MP, and the International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program: Monotherapy with meropenem versus combination therapy with ceftazidime plus amikazin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrobial Agents and Chemotherapy (1996) 40:1108-1115
21. Jackson JJ, Kropp H: Differences in mode of action of β-lactam antibiotics influence morphology, LPS release and in vivo antibiotic efficacy. Journal of Endotoxin Research (1996) 3:201-218
22. Horii T, Kobayashi M, Sato K, Ichiyama S, Ohta M: An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli. Journal of Antimicrobial Chemotherapy (1998) 41:435-442
23. Drusano GL, Hutchinson M: The pharmacokinetics of meropenem. Scandinavian Journal of Infectious Diseases (1995) Supplement 96:11-16
24. McConnell JS, Cohen J: Release of endotoxin from Escherichia coli by quinolones. Journal of Antimicrobial Chemotherapy (1986) 18:765-766
25. Bucklin SE, Morrison DC: Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. Journal of Infectious Diseases (1995) 172:1519-1527
26. Jackson JJ, Kropp H: 3. Carbapenem- and cephalosporin-induced release of lipopolysaccharide from smooth and rough Pseudomonas aeruginosa: in vivo relevance. In: Faist E (ed): Differential release and impact of antibiotic-induced endotoxin. Merck, Whitehouse, NJ (1995) pp. 21-35
27. Dofferhoff ASM, Nijland JH, de Vries-Hospers HG, Mulder POM, Weits J, Bom VJJ: Effect of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in vitro and in vivo study. Scandinavian Journal of Infectious Diseases (1991) 23:745-754